analytics_image
Atrial Fibrillation Market to Reach Valuation of USD 38.9 Billion by 2030 – Increasing approval of products and increase in the prevalence of Atrial Fibrillation Drives the Market
Vantage Market Research

Press Release-Atrial Fibrillation Market to Reach Valuation of USD 38.9 Billion by 2030 – Increasing approval of products and increase in the prevalence of Atrial Fibrillation Drives the Market

Vantage Market Research |

Atrial Fibrillation Market to Reach Valuation of USD 38.9 Billion by 2030 – Increasing approval of products and increase in the prevalence of Atrial Fibrillation Drives the Market

image

In terms of revenue, the Global Atrial Fibrillation Market is expected to reach USD 38.9 Billion by 2028, growing at a CAGR (Compound Annual Growth Rate) of 12.1% from 2022 to 2028.

The rapid growth of the elderly population is driving the Atrial Fibrillation Market along with the increasing incidence of Atrial Fibrillation Market in the elderly population. Additionally, growth in emerging treatments such as the catheter ablation technique, used to treat abnormal heart rhythms when drugs are not working, is expected to drive the market. Over the past 20 years, the number of cases of Atrial Fibrillation Market has increased worldwide. The raising cases in the U.S. by approximately 200,000 to 400,000 each year prompted the growth of the market. In the treatment of atrial fibrillation, the increased use of cardiac monitoring systems led to the surgical segment generating the largest revenue in 2020. With the increasing number of patients suffering from cardiac arrhythmia or irregular heartbeat, the demand for cardiac monitors is also increasing which will propel the growth of the market.

Key Highlights from the Report

·Based on the Procedures, Non-Pharmacological treatment had the highest revenue in 2020 due to the increasing use of a cardiac monitoring system in the treatment of atrial fibrillation. The increasing number of patients suffering from arrhythmias or irregular heartbeats has increased the demand for heart rate monitors.

·Based on the End User, Hospitals segment has registered highest revenue in 2020, owning to increase in adoption of laser and radiofrequency method for catheter ablation.

·On the basis of geographic regions, the global Atrial Fibrillation Market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America achieved the highest sales in the Atrial Fibrillation Market in 2020. High popularity of high-tech Atrial Fibrillation Market treatment devices in North America countries is the main development driver of Atrial Fibrillation Market.

Market Dynamics

Technological advances are driving the Atrial Fibrillation Market. Advanced catheter ablation to treat Atrial Fibrillation Market and reduce the risk of stroke in patients is produced by the big players. Connect and manage different tools and applications on one platform. The unified ecosystem these solutions provide is favored by many organizations around the world. The growth of the Atrial Fibrillation Market is attributed to the increase in the incidence of Atrial Fibrillation Market in the elderly population and the technical development of the treatment of atrial fibrillation. Catheter ablation is increasingly used in the treatment of cardiac arrhythmia because it is a low-risk and minimally invasive method with a success rate of 95.0%.There is a growing need for the most common surgical device used to treat arrhythmias, the catheter ablation device, which removes damaged heart tissue and causes the heart to beat irregularly.

The novel coronavirus (COVID-19) spread rapidly in different countries and regions in 2019, causing a tremendous impact on people's lives and the growth of the Atrial Fibrillation Market. The COVID-19 pandemic has slowed down; the manufacturing of many products in the Atrial Fibrillation Market due to lockdowns. The introduction of the vaccine for COVID-19 in the market has led to the reopening of large Atrial Fibrillation Market stores. This is expected to help grow and regain the market share of atrial fibrillation. As COVID-19 cases begin to decline, equipment and machinery manufacturers must focus on protecting their workforce, operations, and supply networks to respond to urgent emergencies and establish new ways of working.

The growing number of new products and technologies are helping the market grow, but one of the limiting factors is the high price of the treatment process. The treatment is expensive and cannot be used every time to bring considerable aid. The growth of the global Atrial Fibrillation Market is also hampered by product recalls.

North America Atrial Fibrillation Market is expected to witness a noteworthy development with a significant growth rate over the analysis period. Notable industry participants Abbott (US), Johnson & Johnson Private Limited (U.S.), Boston Scientific Corporation (US), are anticipated to accelerate market growth in the area. In addition, the rapidly increasing incidence of heart disease in an aging population poses a major challenge for healthcare systems. Therefore, to meet this challenge, many new products are being approved and launched in North America countries, further stimulating the development of the Atrial Fibrillation Market. The Asia Pacific region is expected to witness the fastest growth during the forecast period 2022 to 2029 owing to the increase in the number of older adults and the increase in disposable income.

The Global Atrial Fibrillation Market is Segmented as follows

  • Types
    • Surgical
    • Non-Surgical
  • Technologies
    • Radio Frequency
    • Laser
    • Cryotherapy
    • Other Technologies
  • End Users
    • Hospitals
    • Specialty Clinics
    • Other End Users
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

List of the Key Players of the Global Atrial Fibrillation Market is

[object Object]

The Global Atrial Fibrillation Market Scope can be Tabulated as below

Parameter Details
Market Size Provided for Years 2016-2028
Base Year 2021
Historic Years 2016-2020
Forecast Years 2022-2028
Segments Covered
  • Types
    • Surgical
    • Non-Surgical
  • Technologies
    • Radio Frequency
    • Laser
    • Cryotherapy
    • Other Technologies
  • End Users
    • Hospitals
    • Specialty Clinics
    • Other End Users
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
Region & Counties Covered
  • North America
    • U.S.
    • Canada
    • Mexic
  • Eurpe
    • U.K
    • France
    • Germany
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Suth Korea
    • South East Asia
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest Of Latin America
  • Middle East & Africa
    • GCC Cuntries
    • South Africa
    • Rest Of Middle East & Africa
Companies Covered
  • Johnson & Johnson (New Brunswick
  • U.S.)
  • Micro Port Scientific Corporation (China)
  • Boston Scientific Corporation (Marlborough
  • U.S.)
  • St. Jude Medical (Saint Paul
  • U.S.)
  • Medtronic PLC (Dublin
  • U.S.)
  • Abbott Laboratories (Chicago
  • U.S.)
  • Biotronik SE & Co. KG (Berlin, Germany)
  • Koninklijke Philips N.V. (Netherlands)
  • Siemens AG (U.S.)
  • AtriCure Inc. (U.S.)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

27 Mar 2023

Min Read

Historical Data | Base Year 

star icon

Access Full Report

Atrial Fibrillation Market to Reach Valuation of USD 38.9 Billion by 2030 – Increasing approval of products and increase in the prevalence of Atrial Fibrillation Drives the Market

This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Request Sample

Related Reports

Healthcare

Veterinary Care Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Latest Press Release

13 Nov 2023

Veterinary Care Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by